obesity treatment with bariatric surgery vs glp-1 receptor agonists Unique and Shared Effects of and GLP-1RA Reversing fibrosis in metabolic dysfunction–associated

According to this characteristic, GLP-1RA gradually entered the clinic

Liraglutide protects nucleus pulposus cells against high-glucose induced apoptosis by activating PI3K/Akt/mTOR/Caspase-3 and PI3K/Akt/GSK3/Caspase-3 signaling pathways

By changing how the brain uses chemicals like dopamine, these drugs may make cravings weaker and easier to ignore

Approximately 57% of patients experienced decrease in appetite, which was consistent across the PIONEER trials [35,36,37,38,39,40,41,42,43,44]

Given that liraglutide and semaglutide comprised the majority of studies, the results are most applicable to these agents, although the pooled analysis incorporated data from the entire GLP-1 RA class